Adiba Hassan1, Victor De Gruttola2,3, Yunyin W Hu4, Zhijuan Sheng4, Kathleen Poortinga4, Joel O Wertheim1. 1. Department of Medicine, University of California, San Diego, California, USA. 2. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. 3. Department of Family Medicine, University of California, San Diego, California, USA. 4. Division of HIV and STD Programs, Los Angeles County Department of Public Health, Los Angeles, California, USA.
Abstract
BACKGROUND: Public health action combating human immunodeficiency virus (HIV) includes facilitating navigation through the HIV continuum of care: timely diagnosis followed by linkage to care and initiation of antiretroviral therapy to suppress viral replication. Molecular epidemiology can identify rapidly growing HIV genetic transmission clusters. How progression through the care continuum relates to transmission clusters has not been previously characterized. METHODS: We performed a retrospective study on HIV surveillance data from 5226 adult cases in Los Angeles County diagnosed from 2010 through 2014. Genetic transmission clusters were constructed using HIV-TRACE. Cox proportional hazard models were used to estimate the impact of transmission cluster growth on the time intervals between care continuum events. Gamma frailty models incorporated the effect of heterogeneity associated with genetic transmission clusters. RESULTS: In contrast to our expectations, there were no differences in time to the care continuum events among individuals in clusters with different growth dynamics. However, upon achieving viral suppression, individuals in high growth clusters were slower to experience viral rebound (hazard ratio 0.83, P = .011) compared with individuals in low growth clusters. Heterogeneity associated with cluster membership in the timing to each event in the care continuum was highly significant (P < .001), with and without adjustment for transmission risk and demographics. CONCLUSIONS: Individuals within the same transmission cluster have more similar trajectories through the HIV care continuum than those across transmission clusters. These findings suggest molecular epidemiology can assist public health officials in identifying clusters of individuals who may benefit from assistance in navigating the HIV care continuum.
BACKGROUND: Public health action combating human immunodeficiency virus (HIV) includes facilitating navigation through the HIV continuum of care: timely diagnosis followed by linkage to care and initiation of antiretroviral therapy to suppress viral replication. Molecular epidemiology can identify rapidly growing HIV genetic transmission clusters. How progression through the care continuum relates to transmission clusters has not been previously characterized. METHODS: We performed a retrospective study on HIV surveillance data from 5226 adult cases in Los Angeles County diagnosed from 2010 through 2014. Genetic transmission clusters were constructed using HIV-TRACE. Cox proportional hazard models were used to estimate the impact of transmission cluster growth on the time intervals between care continuum events. Gamma frailty models incorporated the effect of heterogeneity associated with genetic transmission clusters. RESULTS: In contrast to our expectations, there were no differences in time to the care continuum events among individuals in clusters with different growth dynamics. However, upon achieving viral suppression, individuals in high growth clusters were slower to experience viral rebound (hazard ratio 0.83, P = .011) compared with individuals in low growth clusters. Heterogeneity associated with cluster membership in the timing to each event in the care continuum was highly significant (P < .001), with and without adjustment for transmission risk and demographics. CONCLUSIONS: Individuals within the same transmission cluster have more similar trajectories through the HIV care continuum than those across transmission clusters. These findings suggest molecular epidemiology can assist public health officials in identifying clusters of individuals who may benefit from assistance in navigating the HIV care continuum.
Authors: Manon Ragonnet-Cronin; Yunyin W Hu; Sheldon R Morris; Zhijuan Sheng; Kathleen Poortinga; Joel O Wertheim Journal: Lancet HIV Date: 2019-02-11 Impact factor: 12.767
Authors: Joel O Wertheim; Ben Murrell; Sanjay R Mehta; Lisa A Forgione; Sergei L Kosakovsky Pond; Davey M Smith; Lucia V Torian Journal: J Infect Dis Date: 2018-11-05 Impact factor: 5.226
Authors: Art F Y Poon; Jeffrey B Joy; Conan K Woods; Susan Shurgold; Guillaume Colley; Chanson J Brumme; Robert S Hogg; Julio S G Montaner; P Richard Harrigan Journal: J Infect Dis Date: 2014-10-13 Impact factor: 5.226
Authors: Roger D Kouyos; Viktor von Wyl; Sabine Yerly; Jürg Böni; Patrick Taffé; Cyril Shah; Philippe Bürgisser; Thomas Klimkait; Rainer Weber; Bernard Hirschel; Matthias Cavassini; Hansjakob Furrer; Manuel Battegay; Pietro L Vernazza; Enos Bernasconi; Martin Rickenbach; Bruno Ledergerber; Sebastian Bonhoeffer; Huldrych F Günthard Journal: J Infect Dis Date: 2010-05-15 Impact factor: 5.226
Authors: Joel O Wertheim; Sergei L Kosakovsky Pond; Lisa A Forgione; Sanjay R Mehta; Ben Murrell; Sharmila Shah; Davey M Smith; Konrad Scheffler; Lucia V Torian Journal: PLoS Pathog Date: 2017-01-09 Impact factor: 6.823
Authors: Erik M Volz; James S Koopman; Melissa J Ward; Andrew Leigh Brown; Simon D W Frost Journal: PLoS Comput Biol Date: 2012-06-28 Impact factor: 4.475
Authors: Alison J Rodger; Valentina Cambiano; Tina Bruun; Pietro Vernazza; Simon Collins; Olaf Degen; Giulio Maria Corbelli; Vicente Estrada; Anna Maria Geretti; Apostolos Beloukas; Dorthe Raben; Pep Coll; Andrea Antinori; Nneka Nwokolo; Armin Rieger; Jan M Prins; Anders Blaxhult; Rainer Weber; Arne Van Eeden; Norbert H Brockmeyer; Amanda Clarke; Jorge Del Romero Guerrero; Francois Raffi; Johannes R Bogner; Gilles Wandeler; Jan Gerstoft; Felix Gutiérrez; Kees Brinkman; Maria Kitchen; Lars Ostergaard; Agathe Leon; Matti Ristola; Heiko Jessen; Hans-Jürgen Stellbrink; Andrew N Phillips; Jens Lundgren Journal: Lancet Date: 2019-05-02 Impact factor: 79.321